BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Boceprevir
1
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 1189 | Download: 1929
2
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM | Browse: 921 | Download: 1762
3
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM | Browse: 1352 | Download: 1850
4
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM | Browse: 1028 | Download: 1923
5
Chronic hepatitis C: This and the new era of treatment
1/15/2016 9:49:00 AM | Browse: 1319 | Download: 1196
6
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM | Browse: 1509 | Download: 1508
7
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection
8/29/2015 5:11:00 PM | Browse: 890 | Download: 1148
8
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM | Browse: 1182 | Download: 1866
9
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM | Browse: 1315 | Download: 1678
10
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM | Browse: 1344 | Download: 1347
11
Grade 4 febrile neutropenia and Fournier’s Syndrome associated with triple therapy for hepatitis C virus: A case report
8/26/2014 2:42:00 PM | Browse: 1052 | Download: 961
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345